Schönfeld L, Scheumann G, Jöckel J
Klinik für Innere Medizin IA, Bundeswehrzentralkrankenhaus, Rübenacherstraße 170, 56072, Koblenz, Deutschland.
Inn Med (Heidelb). 2024 Aug;65(8):840-842. doi: 10.1007/s00108-024-01685-4. Epub 2024 Mar 14.
A 60-year-old male patient presented with ischemic-embolic stroke. Transesophageal echocardiography revealed the cause to be aortic valve endocarditis with highly eccentric aortic valve regurgitation. The blood cultures taken several times remained sterile. The indication for surgical aortic valve replacement was made. Conventional microbiological work-up of the heart valve did not reveal any pathogens. The additional molecular genetic testing using eubacterial PCR ("polymerase chain reaction" [PCR]) finally demonstrated the presence of Tropheryma whipplei. A number of therapeutic options were available. The authors decided on intravenous antibiotic therapy with ceftriaxone for 14 days and follow-up therapy with oral trimethoprim/sulfamethoxazole for 1 year. The case illustrates the importance of additional molecular diagnostics beyond the conventional methods in blood culture-negative endocarditis to identify the pathogen and initiate appropriate therapy.
一名60岁男性患者出现缺血性栓塞性中风。经食管超声心动图显示病因是主动脉瓣心内膜炎伴高度偏心性主动脉瓣反流。多次采集的血培养结果均为无菌。遂决定进行主动脉瓣置换手术。对心脏瓣膜进行的常规微生物学检查未发现任何病原体。使用真细菌聚合酶链反应(PCR)进行的额外分子遗传学检测最终证实存在惠普尔嗜组织细胞菌。有多种治疗选择。作者决定采用静脉注射头孢曲松14天,随后口服甲氧苄啶/磺胺甲恶唑进行为期1年的后续治疗。该病例说明了在血培养阴性的心内膜炎中,除常规方法外进行额外分子诊断对于识别病原体和启动适当治疗的重要性。